| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate |
1991-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2c9840b786005dce03de39706f64f70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3fc41a11f8c78ccb990d4c45b75832e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6a8a23ca58b09f4d93cd3179f2336c0 |
| publicationDate |
1992-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2096532-A1 |
| titleOfInvention |
New human recombinant gamma-interferon |
| abstract |
The invention concerns a new mutant of .gamma.-IFN. This new polypep-tide contains 134 amino acids. Amino acids 1 to 132 are the same as those of natural .gamma.-interferon. The first amino acid, methionine, in the zero posi-tion is also present, as has been demonstrated by protein sequencing. The amino acid in position 133 is leucine instead of glutamine. The invention also concerns DNA sequences and plasmid DNA (DSM 6238) which codes for this new polypeptide. The invention further concerns the use of the polypeptide as a drug as well as its use as a fine-chemical reagent for in vitro experiments. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6958388-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7230081-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7232562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7524931-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7419805-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7504237-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7038015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7390638-B2 |
| priorityDate |
1990-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |